CHROMA
LIVE

Serial Number

98113085

Owner

GENERATE BIOMEDICINES, INC.

Attorney

Jennifer M. Mikulina

First Use Date

Nov 15, 2023

Filing Date

Aug 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CHROMA Trademark

Serial Number: 98113085 • Registration: 7562466

CHROMA is a trademark filed by GENERATE BIOMEDICINES, INC. on August 2, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GENERATE BIOMEDICINES, INC. (17 trademarks)

55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

August 2, 2023

Registration Date

November 12, 2024

First Use Anywhere

November 15, 2023

First Use in Commerce

November 15, 2023

Published for Opposition

August 27, 2024

Goods & Services

Downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity in connection with pharmaceutical drug discovery and development; downloadable artificial intelligence software for use in the field of healthcare for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity

Research, development, and design of pharmaceuticals and medicines for others; scientific research in the field of pharmaceutical and medicine design, discovery and development services for others; research and development of technology for others in the field of pharmaceuticals; research and development of technology for others in the field of computational biology; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development for others; collecting and analyzing complex biological data through the use of artificial intelligence, namely, data automation and collection service using proprietary software to evaluate, analyze and collect biological data; computer assisted molecule design involving the use of artificial intelligence technology, namely, product design and development in the field of medicine; conducting scientific and pharmaceutical artificial intelligence research services for others to identify molecules and compounds for drug development, namely, scientific research in the field of pharmaceuticals; providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction; providing online non-downloadable self-learning and artificial intelligence software for use in the field of healthcare for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 3, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 3, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 3, 2025 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 3, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 3, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 12, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 3, 2024 TROA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Apr 11, 2024 AAUA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 10, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 10, 2024 CNRT
USE AMENDMENT ACCEPTED
Apr 10, 2024 IUAA
ASSIGNED TO EXAMINER
Apr 3, 2024 DOCK
AMENDMENT TO USE PROCESSING COMPLETE
Dec 12, 2023 AUPC
USE AMENDMENT FILED
Dec 12, 2023 IUAF
TEAS AMENDMENT OF USE RECEIVED
Dec 11, 2023 EAAU
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2023 NWOS
NEW APPLICATION ENTERED
Aug 5, 2023 NWAP